The growing strength of China’s drug pipelines has gone hand-in-hand with a steep uptick in big pharma licensing deals.

DUBLIN--(BUSINESS WIRE)--The "Royalty Rates in Pharmaceutical and Biotechnology Deals" report has been added to ResearchAndMarkets.com's offering. Royalty Rates in Pharmaceutical and Biotechnology ...

WÄDENSWIL, Switzerland--(BUSINESS WIRE)--Numab Therapeutics AG (“Numab”) and Ono Pharmaceutical Co., Ltd. (“Ono”) today announced that Ono has exercised its option to enter into a development and ...

Gilead Sciences recently broke ground on a 180,000-square-foot AI-enabled Pharmaceutical Development and Manufacturing Technical Development Center at its Foster City campus, part of a US$32 billion ...

Chugai Pharma & Rani Therapeutics ink agreement to develop and commercialize oral formulation leveraging RaniPill technology: Tokyo Wednesday, October 22, 2025, 12:00 Hrs [IST] Ch ...

The CPHI Pharma Awards 2025 shortlist highlights advancements in synthetic biology, AI, patient access, and sustainable packaging, reflecting evolving industry priorities. The awards emphasize ...

He said the government is implementing the Eighth National Development Plan (8NDP), which places science, technology, and ...

LTS LOHMANN Therapie-Systeme AG ("LTS"), a leading pharmaceutical technology company today announces the acquisition of Renaissance Lakewood, LLC ("Renaissance"), a US-based contract development ...